Category Archives: Cancer Therapies

CTCA Gives Rigorous Treatment

Individuals that desire a rewarding and exciting career should check into the fantastic jobs available at Cancer Treatment Centers of America. This leader in adult patient cancer care and research has 5 large hospital campuses now in various United States cities. Careers in oncology are a fast moving upward job market, and this trend is sure to continue for many years. Oncology offers a way for people to use their compassion and job passion energies for something good. Cancer patients need a lot of support to get through their rigorous treatment regimens. Both clinical and non-clinical job opportunities with terrific additional benefits are available.

CTCA has long been known as a premier cancer research center too. Various job openings in the research side of cancer treatment offers individuals plenty of high paying research jobs. These jobs give people a chance to use their own creativity. Other cancer specialists often look to CTCA for information on the latest treatment drugs, therapies and other cancer treatment care options. This healthcare facility hires a wide range of clinical specialists. Oncology nurses can always find a career path within the CTCA network. Others get immense satisfaction in hospitality and other various administrative job positions.

Housekeepers and dietary staff members all are important cogs in the CTCA great wheel. Their input in bettering their department’s current phenomenal patient care is always encouraged. Every person employed by Cancer Treatment Centers of America is an important member of this caring healthcare provider’s close-knit family of caregivers. Drivers, IT technicians, secretarial, human resource, concierge, hospitality, food services, laundry, housekeeping, phone operators and many more supportive department positions give everyone a chance to be employed in a job that people can be proud of. CTCA offers tremendous salaries, employee benefits, continuing education, healthcare benefit options and more. Working for this excellent healthcare company is a dream come true for many employees.

It is not hard to see why so many employees spend their entire careers at a CTCA location. As there are a number of career pathways in this huge healthcare network, employees can change jobs without losing their accumulated employee benefits. Since this is a healthcare provider, certain job positions are available on all shifts and even weekends. This is great for young parents, college students and those people wanting a part time position. The work environment is one of the best in the industry according to many anonymous employee surveys and comments. Come join an elite team of healthcare employees that specialize in caring cancer care. Therapists also are important employees that give patients someone else to lean on. Look up the current job listings at Cancer Treatment Centers of America’s highly detailed and informative website soon.

Oncotarget Gives Great News to those with PTC

The nationally peer-reviewed journal Oncotarget is responsible for the resurgence of research on the pathological effects of cancer treatment and cancer diagnosis. Oncotarget firmly and rightly believes that the more hope a patient feels when going through the battle of cancer the greater chance they will survive the ordeal. They have found that many factors contribute to an overall feeling of hope including things to look forward to in the future, family support systems, and religious observance.

Oncotarget routinely examines various programs that manage cancer and pain to review them based on their ability to increase a patient’s quality of life. Check the journal at SCImago Journal & Country Rank.

Oncotarget recently sat down with Dr. Carmelo Nucero to interview him on his breakthrough research concerning papillary thyroid carcinoma. For those who may not know, papillary thyroid carcinoma has long been known to oncologists as the “resistant cancer.” This is due to its ability to develop a resistance to vemurafenib which targets the BRAF gene which is the cause of papillary thyroid carcinoma. This has led to many patients watching as their cancer goes into remission only to be called back into the oncologist office to be told that their cancer is now drug-resistant and incurable.

Dr. Carmelo Nucero was tired of being unable to give them the hope they desired, so he began taking many years to research how to make papillary thyroid carcinoma less resistant to the drug vemurafenib. He was able to find that when vemurafenib was mixed with palbociclib that both drugs became more effective.

What would happen is that the body would begin recognizing vemurafenib as a domestic substance. Once that occurred the two drugs were able to work in harmony and palbociclib promoted stronger cell regeneration of healthy cells while vemurafenib was able to promote more cell elimination for the cancer cells. Learn more about Oncotarget at Eurekalert.org.

Dr. Carmelo Nucero says that the FDA seems favorable the passage treatment since both drugs have Artie been approved previously.

To stay up-to-date on the news regarding Dr. Carmelo Nucero’s research and much more, subscribe to Oncotarget’s podcast which is available on iTunes and the Google play store.

Follow: https://twitter.com/oncotargetjrnl?lang=en

Just Who Is Dr. Clay Siegall

There are some truly great individuals who have graced us with their presence throughout history. unfortunately, many of these individuals never seem to get introduced into our households. The perfect example of this notion comes in the form of a man named Clay Siegall. Siegall is a scientist, a doctor, a philanthropist and an author. The guy has written up to 70 successful publications, and he’s the current holder of at least 15 patents. Clay Siegall is the CEO, Founder and President of the nation’s largest biotech company. Seattle Genetics is its name and fighting cancer is its game.

This company is located in Bothell, Washington, and it has revolutionized the industry with its cancer fighting medications. These medications are some of the most innovative drugs on the market today. Antibody-Based Therapies deliver a cell killing blow to cancer cells within the body. These medications attacks the cells and destroys them with little-to-no side effects. Unlike chemotherapy and other cancer fighting medications, these advanced therapies decreases the ill effects, which can make the patient feel even sicker. Siegall is the man in charge of it all, and he has helped the company to excel by obtaining multiple strategic licenses for distribution. This distribution allow the medications to be used in other countries. As of today, the medications are being used in 65 countries.

Dr. Siegall has used his brilliant way of thinking, his knowledge, and his expertise to secure this deal and with many more drugs in the pipeline, Seattle Genetics will continue to grow. Siegall posts the updated information on his blog. This blog is used to discuss what’s going on in the cancer research society as well as other interesting topics. One of his latest posts was for the criticism of the Paris Climate Agreement. Siegall also spoke on random topics such as science and politics.

Thanks to his profound interest in saving lives, Siegall has become the “go to” guy for research. Who knows what the future may hold, but the fight against cancer has made much more progress than eras of the past.